Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wulff

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
Acta Physiologica (Oxford, England)|March 3, 2011
Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channelsA-L Hasenau, G Nielsen, C Morisseau, et al.
Experimental Biology and Medicine (Maywood, N.J.)|October 26, 2007
Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaquesL E Pereira, F Villinger, H Wulff, et al.
American Journal of Epidemiology|March 1, 1974
Epidemic of adenovirus type 7 acute conjunctivitis in swimmersG G Caldwell, N J Lindsey, H Wulff, et al.
Bulletin of the World Health Organization|January 1, 1975
Lassa fever in Onitsha, East Central State, Nigeria in 1974G S Bowen, O Tomori, H Wulff, et al.
Bioinformatics (Oxford, England)|January 15, 2015
NLR-parser: rapid annotation of plant NLR complementsBurkhard Steuernagel, Florian Jupe, Kamil Witek, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2017
Generation of Loss-of-Function Mutants for Wheat Rust Disease Resistance Gene CloningRohit Mago, Bradley Till, Sambasivam Periyannan, et al.
Klinische Wochenschrift|October 3, 1983
[Mathematical models in hematology]H E Wichmann, M Loeffler, P Herkenrath, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2000
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressantH Wulff, M J Miller, W Hansel, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 1, 2001
Potassium channels in T lymphocytes: toxins to therapeutic immunosuppressantsK G Chandy, M Cahalan, M Pennington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 2008
Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosisD L Tharp, B R Wamhoff, H Wulff, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Acta Physiologica (Oxford, England)|March 3, 2011
Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channelsA-L Hasenau, G Nielsen, C Morisseau, et al.
Experimental Biology and Medicine (Maywood, N.J.)|October 26, 2007
Pharmacokinetics, toxicity, and functional studies of the selective Kv1.3 channel blocker 5-(4-phenoxybutoxy)psoralen in rhesus macaquesL E Pereira, F Villinger, H Wulff, et al.
American Journal of Epidemiology|March 1, 1974
Epidemic of adenovirus type 7 acute conjunctivitis in swimmersG G Caldwell, N J Lindsey, H Wulff, et al.
Bulletin of the World Health Organization|January 1, 1975
Lassa fever in Onitsha, East Central State, Nigeria in 1974G S Bowen, O Tomori, H Wulff, et al.
Bioinformatics (Oxford, England)|January 15, 2015
NLR-parser: rapid annotation of plant NLR complementsBurkhard Steuernagel, Florian Jupe, Kamil Witek, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 1, 2017
Generation of Loss-of-Function Mutants for Wheat Rust Disease Resistance Gene CloningRohit Mago, Bradley Till, Sambasivam Periyannan, et al.
Klinische Wochenschrift|October 3, 1983
[Mathematical models in hematology]H E Wichmann, M Loeffler, P Herkenrath, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2000
Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressantH Wulff, M J Miller, W Hansel, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 1, 2001
Potassium channels in T lymphocytes: toxins to therapeutic immunosuppressantsK G Chandy, M Cahalan, M Pennington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 2008
Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosisD L Tharp, B R Wamhoff, H Wulff, et al.
Pageof 17